Redirecting TRAIL to tumor blood vessels: Chemical engineering of RGD-targeted proteins.
Marc Tarrus(University of Groningen), Robbert J. Kok(Utrecht University), Grietje Molema(University Medical Center Groningen), Klaas Poelstra(University of Groningen), S Muskee, Almer M. van der Sloot(Mila - Quebec Artificial Intelligence Institute), Kai Temming(University of Groningen), Marie‐Lise Lacombe(Hôpital Saint- Camille), Paul van der Hoeven
Data Archiving and Networked Services (DANS)
December 15, 2005
Cited by 0
Related Papers
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285